Demystifying the black box warning on antidepressants: A protocol for safe prescribing in your practice

Article

Don't let the FDA warning about suicidality discourage you from prescribing an antidepressant for the child or adolescent who needs it. These recommendations provide a guide to monitoring patients for suicidal ideation and other adverse effects.

Recent Videos
Lewis Romer, MD
Susan Carnell, PhD
Robert Frenck, MD | Image credit: Cincinnati Children's
Susan Carnell, PhD
Russell Libby, MD, FAAP
Russell Libby, MD, FAAP
Greg Forlenza, MD
Lawrence Eichenfield, MD
Nathan Kuppermann, MD, MPH
COVID-19 Roundtable: Considering off label therapies
© 2025 MJH Life Sciences

All rights reserved.